Market Cap 2.40B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 9,369,322
Avg Vol 8,703,602
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 74%
Beta 1.14
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
NasdaqFrontier
NasdaqFrontier Jul. 8 at 8:23 PM
$ABCL just added Dr. Lynn Seely to the board, a legit biotech operator with deep experience. Feels like a move to tighten execution as more antibody programs push into clinical development. Leadership quality matters more when the pipeline starts getting real.
0 · Reply
Arnoldsens
Arnoldsens Jul. 8 at 8:23 PM
$ABCL Out of 20 stocks or so that I have this and ABSI were the only ones that didn't recover today. Didn't even make an attempt.
0 · Reply
WallStreetGrowth
WallStreetGrowth Jul. 8 at 8:22 PM
$ABCL adds Dr. Lynn Seely to the board, bringing real biotech execution experience as more antibody programs move into the clinic. Leadership changes like this matter when a pipeline starts getting closer to data. Market will likely watch for follow-through on development progress.
0 · Reply
DeMampCamp
DeMampCamp Jul. 8 at 8:18 PM
$ABCL Sure and imagine if you just kept your original position at $3.50
0 · Reply
Gjhf2782
Gjhf2782 Jul. 8 at 7:42 PM
$ABCL Can’t believe the short interest is still in the mid-teens with all of the tailwinds in place.
1 · Reply
bonecrack_benny
bonecrack_benny Jul. 8 at 7:34 PM
$ABCL Thank you!
0 · Reply
nUme22
nUme22 Jul. 8 at 7:15 PM
$ABCL will but at 6.50 soon
1 · Reply
KryptonResearch
KryptonResearch Jul. 8 at 5:49 PM
AI-enabled healthcare/research is the most obvious massive winner… $ABCL $SLS $RXRX $IBRX $TEM etc… We take a look at a lesser known name in this space, with similar, if not greater upside potential given their ownership of the data layer. This is the next big sector, we have our pick, but there are so many names that will pay well. https://kryptonresearch.substack.com/p/blood-money
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 8 at 5:45 PM
$ABCL “If you listen to others you will be blown of course.” - Carl Hansen, CEO of $ABCL Bruce Lee took this idea to another level "Absorb what is useful, discard what is useless, and add what is specifically your own.” - Bruce Lee
0 · Reply
Arnoldsens
Arnoldsens Jul. 8 at 5:38 PM
$ABCL Closed yesterday at 7.69. Nasdaq turned green- doesn't make sense that they are still selling.
1 · Reply
Latest News on ABCL
AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 1 day ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 2 days ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 2 days ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 4 weeks ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 2 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 2 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 3 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 4 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 4 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 6 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 8 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 8 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 10 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


NasdaqFrontier
NasdaqFrontier Jul. 8 at 8:23 PM
$ABCL just added Dr. Lynn Seely to the board, a legit biotech operator with deep experience. Feels like a move to tighten execution as more antibody programs push into clinical development. Leadership quality matters more when the pipeline starts getting real.
0 · Reply
Arnoldsens
Arnoldsens Jul. 8 at 8:23 PM
$ABCL Out of 20 stocks or so that I have this and ABSI were the only ones that didn't recover today. Didn't even make an attempt.
0 · Reply
WallStreetGrowth
WallStreetGrowth Jul. 8 at 8:22 PM
$ABCL adds Dr. Lynn Seely to the board, bringing real biotech execution experience as more antibody programs move into the clinic. Leadership changes like this matter when a pipeline starts getting closer to data. Market will likely watch for follow-through on development progress.
0 · Reply
DeMampCamp
DeMampCamp Jul. 8 at 8:18 PM
$ABCL Sure and imagine if you just kept your original position at $3.50
0 · Reply
Gjhf2782
Gjhf2782 Jul. 8 at 7:42 PM
$ABCL Can’t believe the short interest is still in the mid-teens with all of the tailwinds in place.
1 · Reply
bonecrack_benny
bonecrack_benny Jul. 8 at 7:34 PM
$ABCL Thank you!
0 · Reply
nUme22
nUme22 Jul. 8 at 7:15 PM
$ABCL will but at 6.50 soon
1 · Reply
KryptonResearch
KryptonResearch Jul. 8 at 5:49 PM
AI-enabled healthcare/research is the most obvious massive winner… $ABCL $SLS $RXRX $IBRX $TEM etc… We take a look at a lesser known name in this space, with similar, if not greater upside potential given their ownership of the data layer. This is the next big sector, we have our pick, but there are so many names that will pay well. https://kryptonresearch.substack.com/p/blood-money
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 8 at 5:45 PM
$ABCL “If you listen to others you will be blown of course.” - Carl Hansen, CEO of $ABCL Bruce Lee took this idea to another level "Absorb what is useful, discard what is useless, and add what is specifically your own.” - Bruce Lee
0 · Reply
Arnoldsens
Arnoldsens Jul. 8 at 5:38 PM
$ABCL Closed yesterday at 7.69. Nasdaq turned green- doesn't make sense that they are still selling.
1 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 8 at 4:33 PM
$ABCL This $ABCL dip was a massive gift
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 8 at 4:23 PM
0 · Reply
QuietLattice
QuietLattice Jul. 8 at 3:41 PM
$ABCL ~5x vol around 9:38, aligned green. day tag back bull. still down ~8%
0 · Reply
sogenerous
sogenerous Jul. 8 at 3:36 PM
$ABCL again its right there - you don't need to be a genius just look at things objectively
1 · Reply
nUme22
nUme22 Jul. 8 at 3:33 PM
$ABCL played it just right .. will reload soon.
0 · Reply
JennyRowes
JennyRowes Jul. 8 at 3:19 PM
$ABCL not worried… we have seen this before
0 · Reply
Rastafari
Rastafari Jul. 8 at 3:16 PM
$ABCL Lift up your sofa pillows and find a few dollars to invest. Today is a good opportunity to buy a few shares. Every share is valuable with this company, I’ve never felt so strong about a CEO ever. Carl is the real deal and if you have a five year horizon, you will be a millionaire with sufficient shares stacked away. Buy, buy, buy!
0 · Reply
DeMampCamp
DeMampCamp Jul. 8 at 3:07 PM
$ABCL Taking us out back by the wood shed today, but seems as if all bios are getting nailed, on-top of many other sectors. Use this time to just focus on other priorities outside of the stock market. Have a great day everyone!
1 · Reply
Cryptocr7
Cryptocr7 Jul. 8 at 10:53 AM
$ABCL but looking ugly across the board
1 · Reply
PorkchopSquats
PorkchopSquats Jul. 8 at 9:32 AM
$ABCL I was looking for a gif of Jeff Goodblum saying “I hate being right”, but I like this one better. Wtf is wrong with people lmao.
1 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 8 at 7:29 AM
$ABCL $ABCL has currently a marketcap of $2.4 billion and liquidity of around $650 Million. Its Discovery Engine will produce every year a potential Blockbuster drug plus the company has a phase 2 readout in September 2026 for ABCL635, a potential 6-10 Billion Dollar drug. Besides all of that the Management has significantly skin in the Game and is incredibly competent. If you think the company is overvalued after its recent run, think again! 🔥
1 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 7 at 9:47 PM
$ABCL I believe that we will hear about the next molecule going into IND enabling studies during this meeting. So many puzzle pieces coming into place. I feel like the momentum is building and this will be a perfect time for it to continue.
0 · Reply